###begin article-title 0
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 55 60 <span type="species:ncbi:9606">human</span>
TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis
###end article-title 0
###begin p 1
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 971 972 971 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1063 1064 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1232 1233 1232 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
###xml 1223 1228 <span type="species:ncbi:9606">human</span>
Whether thymic stromal lymphopoietin (TSLP) directly induces potent human CD4+ T cell proliferation and Th2 differentiation is unknown. We report that resting and activated CD4+ T cells expressed high levels of IL-7 receptor a chain but very low levels of TSLP receptor (TSLPR) when compared with levels expressed in myeloid dendritic cells (mDCs). This was confirmed by immunohistology and flow cytometry analyses showing that only a subset of mDCs, with more activated phenotypes, expressed TSLPR in human tonsils in vivo. IL-7 induced strong STAT1, -3, and -5 activation and promoted the proliferation of naive CD4+ T cells in the presence of anti-CD3 and anti-CD28 monoclonal antibodies, whereas TSLP induced weak STAT5 activation, associated with marginally improved cell survival and proliferation, but failed to induce cell expansion and Th2 differentiation. The effect of TSLP on enhancing strong human T cell proliferation was observed only when sorted naive CD4+ T cells were cultured with mDCs at levels as low as 0.5%. TSLP could only induce naive CD4+ T cells to differentiate into Th2 cells in the presence of allogeneic mDCs. These results demonstrate that IL-7 and TSLP use different mechanisms to regulate human CD4+ T cell homeostasis.
###end p 1
###begin p 2
###xml 150 173 150 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Stockinger et al., 2006</xref>
###xml 175 192 175 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Surh et al., 2006</xref>
###xml 194 213 194 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Boyman et al., 2007</xref>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 409 433 409 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Goldrath and Bevan, 1999</xref>
###xml 435 462 435 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Murali-Krishna et al., 1999</xref>
###xml 464 480 464 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Tan et al., 2001</xref>
###xml 482 497 482 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Ge et al., 2002</xref>
###xml 499 520 499 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Surh and Sprent, 2002</xref>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 654 678 654 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Goldrath and Bevan, 1999</xref>
###xml 680 700 680 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Schluns et al., 2000</xref>
###xml 702 718 702 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Tan et al., 2001</xref>
###xml 720 735 720 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Ge et al., 2002</xref>
###xml 737 758 737 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Surh and Sprent, 2002</xref>
###xml 760 781 760 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Akamatsu et al., 2008</xref>
###xml 903 904 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 914 934 914 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Geginat et al., 2001</xref>
###xml 936 956 936 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
###xml 1046 1047 1046 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1065 1085 1065 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Sport&#232;s et al., 2008</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
In peripheral lymphoid tissues, the number and repertoire diversity of T cells are maintained throughout life by a process called T cell homeostasis (Stockinger et al., 2006; Surh et al., 2006; Boyman et al., 2007). In mice, the homeostatic maintenance of naive and memory CD4+ T cells and of naive CD8+ T cells has been shown to require both TCR signaling by the self-peptide-MHC and cytokines such as IL-7 (Goldrath and Bevan, 1999; Murali-Krishna et al., 1999; Tan et al., 2001; Ge et al., 2002; Surh and Sprent, 2002). The homeostasis of CD8+ memory T cells can be maintained by cytokines such as IL-7, IL-15, and thymic stromal lymphopoietin (TSLP; Goldrath and Bevan, 1999; Schluns et al., 2000; Tan et al., 2001; Ge et al., 2002; Surh and Sprent, 2002; Akamatsu et al., 2008). Previous studies have demonstrated that IL-7 can directly promote the survival and proliferation of activated human CD4+ T cells (Geginat et al., 2001; Rochman et al., 2007). Recently, a clinical study demonstrated that IL-7 can induce the expansion of human CD4+ T cells in vivo (Sportes et al., 2008).
###end p 2
###begin p 3
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 295 316 295 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Soumelis et al., 2002</xref>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 450 429 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Watanabe et al., 2004</xref>
###xml 452 468 452 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Ito et al., 2005</xref>
###xml 470 487 470 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Wang et al., 2006</xref>
###xml 526 527 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 646 666 646 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 818 819 818 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 870 891 870 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Al-Shami et al., 2004</xref>
###xml 893 910 893 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Zhou et al., 2005</xref>
###xml 912 927 912 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">He et al., 2008</xref>
###xml 978 979 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1020 1043 1020 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Omori and Ziegler, 2007</xref>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 421 427 <span type="species:ncbi:9606">humans</span>
###xml 517 522 <span type="species:ncbi:9606">human</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 945 950 <span type="species:ncbi:10090">mouse</span>
Although it is well established that IL-7 directly acts on CD4+ T cells, the relative importance of TSLP versus IL-7 in direct regulation of human CD4+ T cell activation and Th2 differentiation is unclear. We have previously shown that TSLP can induce Th2 differentiation of naive CD4+ T cells (Soumelis et al., 2002) or robust homeostatic expansion of naive and Th2 memory CD4+ T cells indirectly via activating mDCs in humans (Watanabe et al., 2004; Ito et al., 2005; Wang et al., 2006). A recent study showed that human CD4+ T cells preactivated through TCR responded potently to TSLP and that this response could be further enhanced by IL-2 (Rochman et al., 2007). Studies using TSLP receptor (TSLPR)-deficient mice have clearly demonstrated that TSLPR expression by CD4+ T cells is essential for TSLP-mediated CD4+ T cell expansion and Th2 differentiation in vivo (Al-Shami et al., 2004; Zhou et al., 2005; He et al., 2008). The ability of mouse TSLP to directly act on CD4+ T cells was also demonstrated in vitro (Omori and Ziegler, 2007).
###end p 3
###begin p 4
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 612 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 947 948 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1083 1104 1067 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al. (2007)</xref>
###xml 1200 1201 1184 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1540 1541 1524 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 61 67 <span type="species:ncbi:9606">humans</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:9606">human</span>
###xml 840 845 <span type="species:ncbi:9606">human</span>
###xml 1214 1219 <span type="species:ncbi:9606">human</span>
###xml 1300 1305 <span type="species:ncbi:9606">human</span>
###xml 1616 1620 <span type="species:ncbi:10090">mice</span>
###xml 1625 1631 <span type="species:ncbi:9606">humans</span>
To determine whether the target cells of TSLP differ between humans and mice and whether TSLP and IL-7 have an equal potency in inducing human CD4+ T cell proliferation, expansion, and differentiation, we undertook four experimental approaches. First, we performed a comprehensive analysis of the expression profile of TSLPR, IL-7Ralpha, and IL-2R common gamma (gammac) chain transcripts in a variety of human immune cell types. Second, TSLPR chain protein expression was analyzed by flow cytometry using a newly generated monoclonal antibody. Third, we measured proliferation of highly purified human naive CD4+ T cells when cultured with TSLP in the presence of anti-CD3 and anti-CD28 mAbs, with or without the addition of myeloid DCs (mDCs) at 1:200 or 1:400 mDC/T cell ratios. And fourth, we analyzed the in vivo expression of TSLPR in human tonsils by immunohistology and flow cytometry. We report in this paper that resting and activated CD4+ T cells expressed high levels of IL-7Ralpha but very low levels of TSLPR when compared with levels expressed in mDCs, as was shown by Rochman et al. (2007). TSLPR expression on activated mDCs is at least 10x higher than that expressed by activated CD4+ T cells. In human tonsils, only a subset of mDCs was found to express TSLPR in vivo. We show that human IL-7 induces much stronger T cell activation, survival, and proliferation than TSLP. TSLP induces strong T cell proliferation only in the presence of mDCs. These data suggest that IL-7 and TSLP use different mechanisms to regulate CD4+ T cell homeostasis, which underscores differences in TSLP biology between mice and humans.
###end p 4
###begin title 5
RESULTS AND DISCUSSION
###end title 5
###begin title 6
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mDCs and CD4+ T cells preferentially express TSLPR and IL-7R complexes, respectively
###end title 6
###begin p 7
###xml 110 129 102 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Pandey et al., 2000</xref>
###xml 131 148 123 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Park et al., 2000</xref>
###xml 150 168 142 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Reche et al., 2001</xref>
###xml 389 397 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 513 529 497 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Ito et al., 2005</xref>
###xml 531 548 515 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Wang et al., 2006</xref>
###xml 719 720 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 882 883 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 930 931 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 994 995 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1124 1145 1108 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al. (2007)</xref>
###xml 1219 1227 1199 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1516 1536 1488 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Noguchi et al., 1993</xref>
###xml 1538 1558 1510 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Russell et al., 1995</xref>
###xml 1560 1577 1532 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Puel et al., 1998</xref>
###xml 1744 1762 1716 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Reche et al., 2001</xref>
###xml 1764 1788 1736 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Allakhverdi et al., 2007</xref>
###xml 1883 1891 1855 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 721 726 <span type="species:ncbi:9606">human</span>
###xml 979 984 <span type="species:ncbi:9606">human</span>
###xml 1163 1168 <span type="species:ncbi:9606">human</span>
###xml 1237 1242 <span type="species:ncbi:9606">human</span>
###xml 1305 1310 <span type="species:ncbi:9606">human</span>
###xml 1453 1458 <span type="species:ncbi:9606">human</span>
The TSLPR complex consists of the IL-7Ralpha chain and the TSLPR chain, which is a homologue of gammac chain (Pandey et al., 2000; Park et al., 2000; Reche et al., 2001). We performed a detailed microarray analysis of messenger RNA (mRNA) expression for the TSLPR, IL-7Ralpha, and gammac chains in a variety of human immune cell types to assess their potential to respond to TSLP or IL-7 (Fig. 1 A). The quality of this microarray data has been validated at the protein and functional levels by previous studies (Ito et al., 2005; Wang et al., 2006). We found that TSLPR chain mRNA was highly expressed by mDCs, especially after activation by anti-CD40 mAb, TSLP, or poly I:C. Activated plasmacytoid DCs (pDCs) and CD34+ human hematopoietic progenitor-derived mast cells were found to express low levels of TSLPR chain mRNA. TSLPR chain expression was undetectable in peripheral CD4+ naive, memory, and effector T cells, total CD8+ T cells, NK cells, and B cells. Interestingly, human naive CD4+ T cells expressed very low levels of TSLPR chain mRNA after anti-CD3 and anti-CD28 mAb activation, confirming a recent study by Rochman et al. (2007). The majority of human immune cell types expressed the IL-7Ralpha chain (Fig. 1 A). Unlike human T cells, which expressed high levels of the IL-7Ralpha chain, human B cells expressed undetectable levels of IL-7Ralpha chain mRNA. This is consistent with previous studies showing that IL-7 is dispensable for human B cell development and B cell-mediated immune responses (Noguchi et al., 1993; Russell et al., 1995; Puel et al., 1998). Our current results confirm those of previous studies showing that mDCs and mast cells are the major cell types that express the TSLPR complex and respond to TSLP (Reche et al., 2001; Allakhverdi et al., 2007). In addition, pDCs can express the TSLPR complex upon CpG-A, -B, -C, Flu, or HSV activation (Fig. 1 A).
###end p 7
###begin p 8
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLPR complex expression on human immune cells.</bold>
###xml 231 247 231 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Ito et al., 2005</xref>
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 324 325 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 353 354 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 541 542 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 568 569 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 901 902 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1082 1083 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1089 1080 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
TSLPR complex expression on human immune cells. (A) Microarray profile of TSLPR and IL-7R complex mRNA expression in human immune cells is shown. Purification of cells and microarray analysis was conducted as previously described (Ito et al., 2005). Cells include the following: CD16+/- monocytes, CD4+CD11c+ mDCs, naive CD4+ T cells, central memory CD4+ T cells, effector memory CD4+ T cells, CD8+ T cells, CD123+BDCA2+pDCs, CD56+ NK cells, CD19+ B cells, CD34+ mast cells, basophils, and eosinophils. Nonstimulated and stimulated CD4+CD11c+ mDCs, pDCs, and naive CD4+ T cells were analyzed as well. The final expression output was normalized with the numerical value of one representing the estimated threshold of basal expression. Bars show the relative mRNA expression of the TSLPR, IL-7Ralpha, and IL-2Rgamma chains in each cell subtype. (B) FACS analysis of TSLPR complex expression in naive CD4+ T cells after indicated days of anti-CD3 and anti-CD28 mAb stimulation is shown. (C) FACS analysis of TSLPR complex expression in freshly isolated, unstimulated, or stimulated CD4+CD11c+ mDCs is shown. In B and C, numbers state the mean fluorescence intensity (MFI) of receptor minus isotype control. Filled histograms represent isotype control, and open histograms represent the staining of the receptor indicated at the left of each histogram. Stimulating conditions are shown at the top of each histogram. Data represents one of five experiments.
###end p 8
###begin p 9
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 436 416 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al. (2007</xref>
###xml 438 446 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 471 472 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 575 583 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 811 819 803 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 124 129 <span type="species:ncbi:9606">human</span>
To further compare TSLPR expression in CD4+ T cells and mDCs at the protein level, we generated a panel of mAbs against the human TSLPR chain for use in flow cytometry. We found that resting naive CD4+ T cells expressed undetectable levels of the TSLPR chain, whereas activated CD4+ T cells expressed very low levels of the TSLPR chain at days 3, 4, 5, and 6 after anti-CD3 and anti-CD28 mAb activation, as shown by Rochman et al. (2007; Fig. 1 B). In contrast, naive CD4+ T cells expressed high levels of the IL-7Ralpha chain, which was further upregulated upon activation (Fig. 1 B). Moreover, freshly isolated mDCs expressed detectable levels of the TSLPR chain and IL-7Ralpha chain, and the expression levels of both were dramatically increased upon culture in medium alone or with IL-7, poly I:C, or TSLP (Fig. 1 C).
###end p 9
###begin title 10
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
IL-7, but not TSLP, directly promotes strong naive CD4+ T cell proliferation
###end title 10
###begin p 11
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 550 566 550 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 (A and B)</xref>
###xml 784 785 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 999 1000 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1113 1114 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1263 1271 1235 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1303 1311 1275 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 1391 1392 1363 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1502 1517 1470 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, E and F</xref>
###xml 1574 1575 1542 1543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1598 1606 1566 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
To determine whether TSLP can directly promote the proliferation of naive CD4+ T cells activated by anti-CD3 and anti-CD28 mAbs, we first carefully titrated the concentration of anti-CD3 mAb to determine suboptimal and optimal doses that could be used to measure the effect of IL-7 or TSLP. Naive CD4+ T cells were purified by a cell sorter to a purity >99%, labeled with CFSE, and then cultured with immobilized anti-CD3 and soluble anti-CD28 mAbs for 7 d. Cell proliferation was measured by FACS and counting the total number of cells. As shown in Fig. 2 (A and B), anti-CD3 mAb at 0.1 or 0.5 microg/ml was unable to induce T cell proliferation in the presence of 1 microg/ml of anti-CD28 mAb. However, 1 microg/ml of anti-CD3 mAb could induce significant proliferation of naive CD4+ T cells, and 2 microg/ml of anti-CD3 mAb could induce the maximum level of proliferation. We then choose the 0.5-microg/ml suboptimal dose of anti-CD3 mAb to test the effect of IL-7 and TSLP on promoting naive CD4+ T cell proliferation. We found that IL-7 at 0.5-62.5 ng/ml could strongly promote the proliferation of naive CD4+ T cells activated with 0.5 microg/ml of anti-CD3 and 1 microg/ml of anti-CD28 mAbs in a dose-dependent fashion, based on CFSE-labeling experiments (Fig. 2 C) and total viable cell counts (Fig. 2 D). However, TSLP at 1-625 ng/ml failed to promote the proliferation of naive CD4+ T cells under the same culture condition or when cultured with the 2-microg/ml optimal dose of anti-CD3 mAb (Fig. 2, E and F). We occasionally observed that TSLP weakly promotes CD4+ T cell proliferation (Fig. 3 A), which was indicated by a small increase in the percentage of CFSE-labeled cells from 13.9 to 20.7%. In contrast, IL-7 increases the percentage of CFSE-labeled cells from 13.9 to 86.4% in the same experiment.
###end p 11
###begin p 12
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-7, and not TSLP, has an additive effect on naive CD4<sup>+</sup> T cell proliferation triggered by anti-CD3 and anti-CD28 mAbs.</bold>
###xml 151 152 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 719 720 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 891 892 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1131 1132 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
IL-7, and not TSLP, has an additive effect on naive CD4+ T cell proliferation triggered by anti-CD3 and anti-CD28 mAbs. CFSE-labeled purified naive CD4+ T cells were cultured for 7 d in the presence of anti-CD28 and anti-CD3 mAbs alone or with either IL-7 or TSLP. The doses of anti-CD28, anti-CD3, IL-7, and TSLP are indicated. T cell proliferation was measured by FACS analysis on day 4 and by cell count on day 7 of culture. For the FACS results, numbers in each square state the percentage of proliferated T cells. For the cell count, data points represent the total number of expanded T cells of a donor, each represented by a different symbol. (A and B) The effect of increasing doses of anti-CD3 mAb on naive CD4+ T cell proliferation is shown. Data represent one of three independent experiments (A) and three donors (B). (C and D) The effect of increasing doses of IL-7 on naive CD4+ T cell proliferation in the presence of anti-CD28 and the suboptimal dose of anti-CD3 mAbs is shown. Data represent one of five independent experiments (C) and five donors (D). (E and F) The effect of increasing doses of TSLP on naive CD4+ T cell proliferation in the presence of anti-CD28 mAb and either the suboptimal or optimal dose of anti-CD3 mAb is shown. Data represent one of five independent experiments (E) and five donors (F).
###end p 12
###begin p 13
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLP stimulates naive CD4<sup>+</sup> T cell proliferation through mDCs.</bold>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
TSLP stimulates naive CD4+ T cell proliferation through mDCs. CFSE-labeled purified naive CD4+ T cells with or without autologous mDCs were cultured for 7 d with anti-CD3 and anti-CD28 mAbs alone or in the presence of TSLP, IL-7, or TSLP plus IL-7. The levels of mDCs and the doses of anti-CD28, anti-CD3, IL-7, and TSLP are indicated. Proliferation of T cells was detected by FACS on day 4 of culture; the percentage of proliferated T cells is indicated in each square. (A) The effect of IL-7 or TSLP on naive CD4+ T cell proliferation with or without autologous mDCs is shown. Data represent one of five independent experiments. (B) The effect of increasing doses of TSLP on naive CD4+ T cell proliferation with or without autologous mDCs is shown. Data represent one of five independent experiments.
###end p 13
###begin title 14
TSLP mediates T cell homeostasis indirectly through mDCs
###end title 14
###begin p 15
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 155 175 155 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 262 282 262 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
###xml 340 348 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 507 528 507 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Soumelis et al., 2002</xref>
###xml 530 551 530 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Watanabe et al., 2004</xref>
###xml 823 824 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 876 884 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 930 931 930 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1076 1084 1076 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Our data demonstrate that human CD4+ T cells express very low levels of TSLPR upon activation with anti-CD3 and anti-CD28 mAbs, confirming a recent study (Rochman et al., 2007). However, we failed to observe that activated CD4+ T cells respond potently to TSLP (Rochman et al., 2007), which is in contrast to their robust response to IL-7 (Fig. 2 E). Because our previous studies have shown that mDCs activated by TSLP potently induce the proliferation of CD4+ T cells at a DC/T cell ratio as low as 1:150 (Soumelis et al., 2002; Watanabe et al., 2004), we next investigated whether addition of a few mDCs could allow TSLP to promote T cell proliferation in the presence of anti-CD3 and anti-CD28 mAbs. We found that the presence of 0.25 and 0.5% of mDCs allowed TSLP to significantly enhance the proliferation of naive CD4+ T cells cultured with anti-CD3 and anti-CD28 mAbs (Fig. 3 A). We also found that TSLPs enhanced naive CD4+ T cell proliferation in a dose-dependent fashion when they were cultured with 0.25 or 0.5% mDCs in the presence of anti-CD3 and anti-CD28 mAbs (Fig. 3 B).
###end p 15
###begin title 16
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 30 35 <span type="species:ncbi:9606">human</span>
TSLP does not directly induce human naive CD4+ T cells to differentiate into Th2 cells
###end title 16
###begin p 17
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 121 144 121 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Omori and Ziegler, 2007</xref>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 559 560 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1075 1076 1067 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1287 1288 1279 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1577 1578 1569 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1616 1637 1608 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Watanabe et al., 2004</xref>
###xml 1639 1656 1631 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Wang et al., 2006</xref>
###xml 1729 1730 1721 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1874 1895 1866 1887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Watanabe et al., 2004</xref>
###xml 1897 1914 1889 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Wang et al., 2006</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
A recent study in mice suggested that TSLP has the ability to induce naive CD4+ T cells to differentiate into Th2 cells (Omori and Ziegler, 2007). To determine whether TSLP can directly induce human naive CD4+ T cells to differentiate into Th2 cells, purified naive CD4+ T cells were mixed with either fresh autologous mDCs at a 1:200 mDC/T cell ratio or with no mDCs and then cultured with anti-CD3 and anti-CD28 mAbs only or in the presence of TSLP, IL-7, anti-IFN-gamma mAb and IL-4, or IFN-gamma and anti-IL-4 mAb for 7 d (). Meanwhile, purified naive CD4+ T cells were cocultured for 7 d with either pretriggered autologous mDCs at a 1:2 mDC/T cell ratio or pretriggered allogenic mDCs at a 1:5 mDC/T cell ratio. Both autologous and allogenic mDCs had been triggered with TSLP or medium for 24 h before coculturing with the T cells (Fig. S1, C and D). After culture, T cells were reactivated with anti-CD3 and anti-CD28 mAbs for 24 h, and the culture medium was collected to measure levels of secreted cytokines by ELISA. We found that TSLP was unable to prime naive CD4+ T cells or T cells mixed with autologous mDCs at a 1:200 mDC/T cell ratio to secrete Th2 cytokines in the presence of anti-CD3 and anti-CD28 mAbs (Fig. S1, A and B). In addition, TSLP could not induce naive CD4+ T cells to differentiate into Th2 cells when they were cocultured with pretriggered autologous mDCs at a 1:2 mDC/T cell ratio (Fig. S1 C). This is consistent with the results of our previous study in which TSLP-activated autologous mDCs induced only homeostatic proliferation of naive CD4+ T cells and not Th2 differentiation (Watanabe et al., 2004; Wang et al., 2006). TSLP only induced strong Th2 differentiation of the cultured naive CD4+ T cells in the presence of pretriggered allogeneic mDCs at a 1:5 mDC/T cell ratio (Fig. S1 D), confirming the results of our previous studies (Watanabe et al., 2004; Wang et al., 2006).
###end p 17
###begin title 18
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
TSLP induced weak STAT1 and STAT5 activation and improved cell survival of naive CD4+ T cells
###end title 18
###begin p 19
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 663 671 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 892 912 892 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
Because anti-CD3 and anti-CD28 mAbs can induce low levels of TSLPR expression in naive CD4+ T cells, we further examined whether TSLP could induce the signal transduced by the TSLPR complex. Naive CD4+ T cells were activated by anti-CD3 and anti-CD28 mAbs for 4 d and then cultured with medium alone, with IL-2, IL-4, IL-7, TSLP alone, or in the presence of an isotype control or neutralizing mAbs against IL-4 or TSLP. Activation of STAT family molecules in the T cells after 20 min of culture was examined by Western blot analysis. We found that all of the cytokines investigated, IL-2, IL-4, and IL-7, induced strong phosphorylation of multiple STAT proteins (Fig. 4 C). In contrast, TSLP only induced a very weak phosphorylation of STAT1 and STAT5, which was blocked by the TSLP-neutralizing mAb but not by the IL-4-neutralizing mAb or the isotype control, which confirms a recent study (Rochman et al., 2007).
###end p 19
###begin p 20
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLP activates weak STAT1 and STAT5 phosphorylation and maintains activated CD4<sup>+</sup> T cell viability.</bold>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 744 745 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
TSLP activates weak STAT1 and STAT5 phosphorylation and maintains activated CD4+ T cell viability. (A) Naive CD4+ T cells, preactivated with anti-CD3 and anti-CD28 mAbs, were restimulated with medium alone or with IL-7, TSLP, or TSLP plus IL-7 for 8 d. Every 2 d during culture, cells were stained with FITC-annexin V and PI and then analyzed by FACS. Numbers in the bottom right and left quarters state the percentage of apoptotic and viable cells, respectively. Numbers in the top right quarters state the percentage of dead cells. Data represent one of five independent experiments. (B) Survival curve based on the percentage of viable cells from experiments described in A. Data represents one of five independent experiments. (C) Naive CD4+ T cells, preactivated with anti-CD3 and anti-CD28 mAbs, were restimulated with medium alone (M) or with IL-2, IL-4, IL-7, TSLP, or TSLP with an isotype control mAb or neutralizing mAbs against IL-4 or TSLP. Activated STAT family molecules were detected by Western blotting with beta-actin serving as an internal control. The molecular mass (M.M.) of each protein is shown parenthetically. Data represent one of four experiments.
###end p 20
###begin p 21
###xml 123 143 123 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Isaksen et al., 2002</xref>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 445 460 445 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, A and B</xref>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 671 672 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 768 769 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 779 794 779 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, A and B</xref>
Because STAT5 activation in T cells has been linked with improved cell survival that is uncoupled with cell proliferation (Isaksen et al., 2002), we further examined whether TSLP could improve the survival of naive CD4+ T cells activated by anti-CD3 and anti-CD28 mAbs. Naive CD4+ T cells were cultured with anti-CD3 and anti-CD28 mAbs for 4 d. Cells were washed and then cultured for 8 d with medium alone or with IL-7, TSLP, or TSLP and IL-7 (Fig. 4, A and B). Viable and apoptotic cells were analyzed by propidium iodide (PI) and annexin V staining at different time points of culture (Fig. 4 A). We found that IL-7 could greatly maintain the survival of activated CD4+ T cells for up to 8 d, whereas TSLP could only marginally improve the survival of activated CD4+ T cells (Fig. 4, A and B).
###end p 21
###begin title 22
###xml 67 72 <span type="species:ncbi:9606">human</span>
A subset of mDC with a more activated phenotype expresses TSLPR in human tonsils in vivo
###end title 22
###begin p 23
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 381 389 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 436 437 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 442 443 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 536 528 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 689 690 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 696 704 696 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 641 646 <span type="species:ncbi:9606">human</span>
To determine TSLPR-expressing cell types in vivo, we performed flow cytometry and immunohistology analyses of cells in human tonsils. We found that a subset of CD4+CD11c+lineage- (CD3, CD14, CD16, CD19, and CD56) mDCs in human tonsils (3.96%) expressed TSLPR (Fig. 5 A). The TSLPR-positive mDCs expressed higher levels of CD40, CD80, CD86, and HLA-DR than the TSLPR-negative mDCs (Fig. 5 A). All the T cell subsets tested, including CD4+, CD8+, and CD4+CD8+ T cells in human tonsils, did not express detectable levels of TSLPR (Fig. 5 B). By immunohistology, TSLPR-expressing cells were found in the T cell areas or interfollicular areas of human tonsils, which represent a subset of CD11c+ DCs (Fig. 5 C).
###end p 23
###begin p 24
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLPR expression in human tonsils.</bold>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 863 864 863 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1004 1005 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
TSLPR expression in human tonsils. (A) FACS analysis of TSLPR, CD40, CD80, CD86, and HLA-DR expression in freshly isolated CD4+CD11c+ mDCs in tonsils is shown. (B) FACS analysis of TSLPR expression in freshly isolated CD4+, CD8+, or CD4+CD8+ T cells in tonsils is shown. (C) Identification of TSLPR-positive cell population in human tonsil tissue by immunohistology is shown. In A, numbers in each histogram state the MFI of receptor minus isotype control. Filled histograms represent isotype control, and open histograms represent the staining of the molecules indicated at the top of each histogram. In B, numbers in each square represents the percentage of cell subsets expressing indicated surface markers. Data represent one of five experiments. In C (i), red cells represent TSLPR-positive population in tonsils. In C (ii), green cells represent tonsil CD20+ B cells; in C (iii), TSLPR-positive cells (red) localize at paracortical zone between the lymphoid follicles (green); in C (iv) among CD11c+ mDCs (green) and TSLPR-positive cells (red), there is a certain population expressing both CD11c and TSLPR (yellow); (i,ii,iii, and iv) magnification, X400. Bars, 50.0 microm.
###end p 24
###begin p 25
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 303 324 303 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al. (2007)</xref>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
In this study, we demonstrate that, unlike IL-7, TSLP does not potently promote proliferation of human naive CD4+ T cells activated by anti-CD3 and anti-CD28 mAbs. TSLPR signaling in activated human naive CD4+ T cells led to only very weak activation of STAT1 and STAT5, as was recently demonstrated by Rochman et al. (2007), and marginally improved cell survival. In contrast, signaling from the IL-7R complex in activated naive CD4+ T cells led to robust activation of STAT1, STAT3, and STAT5, strong T cell proliferation, and prolonged T cell survival.
###end p 25
###begin p 26
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
Both in vitro and in vivo data of our present study shows that human mDCs express very high levels of the TSLPR complex. TSLPR expression levels correlate with the function of TSLP. We have previously demonstrated that TSLP-primed DCs can induce the robust expansion of naive CD4+ T cells in both allogenic and autologous systems. In the present study, we found that even at the very low mDC/T cell ratio of 1:200 TSLP could strongly promote the proliferation of naive CD4+ T cells in culture with anti-CD3 and anti-CD28 mAbs. These results indicate that human IL-7 and TSLP use two different but complementary mechanisms to regulate peripheral T cell homeostasis. IL-7 has a potent and direct effect on T cell activation and displays a limited effect on mDCs, and TSLP predominantly acts on mDCs and has a moderate effect directly on T cells.
###end p 26
###begin title 27
MATERIALS AND METHODS
###end title 27
###begin title 28

###end title 28
###begin title 29
Microarray analysis.
###end title 29
###begin p 30
###xml 59 75 59 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Ito et al., 2005</xref>
Microarray analysis was performed as described previously (Ito et al., 2005).
###end p 30
###begin title 31
mDC isolation and culture.
###end title 31
###begin p 32
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 440 456 440 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Ito et al., 2005</xref>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 295 303 <span type="species:ncbi:9606">Children</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
The institutional review board for human research at The University of Texas M.D. Anderson Cancer Center (Houston, TX) approved this study. A FACSAria (BD) was used to purify (>99%) CD4+CD11c+lineage- mDCs from buffy coats (Gulf Coast Regional Blood Center, Houston, TX) or human tonsils (Texas Children's Hospital, Houston, TX). The mDCs were cultured in RPMI medium (Invitrogen) containing 2% human AB serum, alone or with 15 ng/ml TSLP (Ito et al., 2005), 10 microg/ml poly I:C (InvivoGen), or 10 ng/ml IL-7 (R&D Systems) for 24 h.
###end p 32
###begin title 33
Naive T cell isolation, culture, and proliferation assays.
###end title 33
###begin p 34
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 72 89 72 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Wang et al., 2006</xref>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 359 360 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 521 522 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 561 562 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 567 568 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 183 188 <span type="species:ncbi:9606">human</span>
CD4+CD45RA+CD45RO- naive T cells were isolated as described previously (Wang et al., 2006). In some assays, the purified naive CD4+ T cells were cultured in RPMI medium containing 4% human AB serum for 7 d in the presence of 2.0 microg/ml of immobilized anti-CD3 and 1.0 microg/ml of soluble anti-CD28 mAbs (BD) unless stated otherwise. CFSE-labeled naive CD4+ T cells were cultured with anti-CD28 and 0.1-5.0 microg/ml of anti-CD3 mAbs alone or with either 0.1-62.5 ng/ml IL-7 or 1-625 ng/ml TSLP. CFSE-labeled naive CD4+ T cells were mixed with autologous CD4+CD11c+ mDCs at either a 1:200 or 1:400 mDC/T cell ratio or mixed without mDCs, and then cultured with anti-CD3 and anti-CD28 mAbs alone or with 0.5 ng/ml IL-7, 5-125 ng/ml TSLP, or 0.5 ng/ml IL-7 and 5-125 ng/ml TSLP. T cell proliferation was measured using a FACSCalibur (BD) and by cell count.
###end p 34
###begin title 35
TSLPR complex expression in mDCs and T cells.
###end title 35
###begin p 36
###xml 18 24 18 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 152 172 152 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Rochman et al., 2007</xref>
Freshly isolated (Fig. 1) or stimulated naive CD4+ T cells and untreated or stimulated mDCs were stained with biotin-labeled anti-TSLPR antibody (2D10; Rochman et al., 2007) or PE-anti-IL-7Ralpha antibody (Beckman Coulter). Cells were washed, stained with APC-streptavidin, and then analyzed with a FACSCalibur.
###end p 36
###begin title 37
Th2 cytokine production analyses.
###end title 37
###begin p 38
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 391 412 383 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Watanabe et al., 2004</xref>
Purified naive CD4+ T cells or T cells mixed with autologous mDCs at a 1:200 mDC/T cell ratio were cultured with anti-CD3 and anti-CD28 mAbs alone or with TSLP, IL-7, TSLP plus IL-7, anti-IL-4 plus IFN-gamma, and anti-IFN-gamma plus IL-4 conditions (Fig. S1). Meanwhile, T cells were cocultured with either autologous or allogenic mDCs, both pretriggered with either TSLP or medium for 7 d (Watanabe et al., 2004). After culturing, the T cells were restimulated with anti-CD3 and anti-CD28 mAbs for 24 h. Medium was collected and used to measure IL-4, IL-5, IL-13, and IFN-gamma levels by ELISA (all kits from R&D Systems).
###end p 38
###begin title 39
Annexin V analyses.
###end title 39
###begin p 40
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Naive CD4+ T cells were TCR triggered for 4 d. Cells were recultured in medium alone or with TSLP, IL-7, or TSLP and IL-7 for 8 d. Every 2 d, the preactivated T cells were stained with FITC-annexin V and PI (BD) and then analyzed with a FACSCalibur.
###end p 40
###begin title 41
Western blot analysis.
###end title 41
###begin p 42
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Naive CD4+ T cells were cultured with anti-CD3 and anti-CD28 mAbs for 4 d and then stimulated with medium alone or with IL-2, IL-4, IL-7, TSLP alone, or in the presence of isotype control or neutralizing mAb against IL-4 or TSLP for 20 min. The activation of STAT1, STAT3, STAT5, and STAT6 was detected by Western blotting using antibodies against the tyrosine-phosphorylated forms of STAT1, STAT3, STAT5, and STAT6 (Cell Signaling Technology). Antibodies against STAT6 (Santa Cruz Biotechnology, Inc.) and beta-actin (Sigma-Aldrich) were used in the analysis as well.
###end p 42
###begin title 43
Immunohistology.
###end title 43
###begin p 44
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
6-microm frozen sections of human tonsil were fixed with cold acetone for 10 min and then incubated with mouse anti-human TSLPR mAb (3G11; our laboratory) at room temperature for 1 h in PBS. The slides were washed with PBS three times and incubated with red fluorescent-labeled secondary antibody (Invitrogen) for 30 min. This was followed by anti-CD20 or anti-CD11c mAbs (BD) staining, and green fluorescent-labeled secondary antibody (Invitrogen) was applied.
###end p 44
###begin title 45
Online supplemental material.
###end title 45
###begin p 46
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Fig. S1 demonstrates that TSLP cannot directly stimulate naive CD4+ T cells to produce Th2 cytokines. Online supplemental material is available at .
###end p 46
###begin p 47
We thank the flow cytometry facility (supported by National Cancer Institute grant P30CA16672) for cell sorting. We thank Dr. Li Zhang for the suggestion of microarray data analysis. We thank Melissa Wentz and Virginia Mohlere for critical reading of the manuscript, and Dr. Warren Leonard for helpful discussion and critical reading of the manuscript.
###end p 47
###begin p 48
This work was supported by the National Institutes of Health grant R01 AI062888-01 awarded to Y.-J. Liu.
###end p 48
###begin p 49
The authors have no conflicting financial interests.
###end p 49
###begin article-title 50
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TSLP directly enhances expansion of CD8+ T cells.
###end article-title 50
###begin article-title 51
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
A role for thymic stromal lymphopoietin in CD4(+) T cell development.
###end article-title 51
###begin article-title 52
###xml 44 49 <span type="species:ncbi:9606">human</span>
Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells.
###end article-title 52
###begin article-title 53
Cytokines and T-cell homeostasis.
###end article-title 53
###begin article-title 54
Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.
###end article-title 54
###begin article-title 55
###xml 53 58 <span type="species:ncbi:9606">human</span>
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.
###end article-title 55
###begin article-title 56
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts.
###end article-title 56
###begin article-title 57
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.
###end article-title 57
###begin article-title 58
Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.
###end article-title 58
###begin article-title 59
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.
###end article-title 59
###begin article-title 60
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Persistence of memory CD8 T cells in MHC class I-deficient mice.
###end article-title 60
###begin article-title 61
Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.
###end article-title 61
###begin article-title 62
Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin.
###end article-title 62
###begin article-title 63
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin.
###end article-title 63
###begin article-title 64
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor.
###end article-title 64
###begin article-title 65
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.
###end article-title 66
###begin article-title 67
###xml 73 78 <span type="species:ncbi:9606">human</span>
Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells.
###end article-title 67
###begin article-title 68
###xml 22 29 <span type="species:ncbi:9606">patient</span>
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
###end article-title 68
###begin article-title 69
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo.
###end article-title 69
###begin article-title 70
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
###end article-title 70
###begin article-title 71
###xml 28 34 <span type="species:ncbi:9606">humans</span>
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.
###end article-title 71
###begin article-title 72
CD4+ memory T cells: functional differentiation and homeostasis.
###end article-title 72
###begin article-title 73
Regulation of naive and memory T-cell homeostasis.
###end article-title 73
###begin article-title 74
Homeostasis of memory T cells.
###end article-title 74
###begin article-title 75
IL-7 is critical for homeostatic proliferation and survival of naive T cells.
###end article-title 75
###begin article-title 76
###xml 32 37 <span type="species:ncbi:9606">human</span>
Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion.
###end article-title 77
###begin article-title 78
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.
###end article-title 78
###begin p 79
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="80">Abbreviations used:</title>
###xml 19 25 19 21 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;c</term>
###xml 25 37 21 29 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="81">common &#947;</p>
###xml 25 37 21 29 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="81">common &#947;</p></def>
###xml 19 37 19 29 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>&#947;c</term><def><p textid="81">common &#947;</p></def></def-item>
###xml 37 40 29 32 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mDC</term>
###xml 40 50 32 42 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="82">myeloid DC</p>
###xml 40 50 32 42 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="82">myeloid DC</p></def>
###xml 37 50 29 42 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>mDC</term><def><p textid="82">myeloid DC</p></def></def-item>
###xml 50 53 42 45 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFI</term>
###xml 53 80 45 72 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="83">mean fluorescence intensity</p>
###xml 53 80 45 72 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="83">mean fluorescence intensity</p></def>
###xml 50 80 42 72 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>MFI</term><def><p textid="83">mean fluorescence intensity</p></def></def-item>
###xml 80 84 72 76 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRNA</term>
###xml 84 97 76 89 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">messenger RNA</p>
###xml 84 97 76 89 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="84">messenger RNA</p></def>
###xml 80 97 72 89 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>mRNA</term><def><p textid="84">messenger RNA</p></def></def-item>
###xml 97 100 89 92 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDC</term>
###xml 100 115 92 107 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">plasmacytoid DC</p>
###xml 100 115 92 107 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">plasmacytoid DC</p></def>
###xml 97 115 89 107 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>pDC</term><def><p textid="85">plasmacytoid DC</p></def></def-item>
###xml 115 117 107 109 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PI</term>
###xml 117 133 109 125 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">propidium iodide</p>
###xml 117 133 109 125 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">propidium iodide</p></def>
###xml 115 133 107 125 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PI</term><def><p textid="86">propidium iodide</p></def></def-item>
###xml 133 137 125 129 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLP</term>
###xml 137 165 129 157 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">thymic stromal lymphopoietin</p>
###xml 137 165 129 157 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">thymic stromal lymphopoietin</p></def>
###xml 133 165 125 157 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TSLP</term><def><p textid="87">thymic stromal lymphopoietin</p></def></def-item>
###xml 0 165 0 157 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="80">Abbreviations used:</title><def-item><term>&#947;c</term><def><p textid="81">common &#947;</p></def></def-item><def-item><term>mDC</term><def><p textid="82">myeloid DC</p></def></def-item><def-item><term>MFI</term><def><p textid="83">mean fluorescence intensity</p></def></def-item><def-item><term>mRNA</term><def><p textid="84">messenger RNA</p></def></def-item><def-item><term>pDC</term><def><p textid="85">plasmacytoid DC</p></def></def-item><def-item><term>PI</term><def><p textid="86">propidium iodide</p></def></def-item><def-item><term>TSLP</term><def><p textid="87">thymic stromal lymphopoietin</p></def></def-item></def-list>
Abbreviations used:gammaccommon gammamDCmyeloid DCMFImean fluorescence intensitymRNAmessenger RNApDCplasmacytoid DCPIpropidium iodideTSLPthymic stromal lymphopoietin
###end p 79
###begin title 80
Abbreviations used:
###end title 80
###begin p 81
common gamma
###end p 81
###begin p 82
myeloid DC
###end p 82
###begin p 83
mean fluorescence intensity
###end p 83
###begin p 84
messenger RNA
###end p 84
###begin p 85
plasmacytoid DC
###end p 85
###begin p 86
propidium iodide
###end p 86
###begin p 87
thymic stromal lymphopoietin
###end p 87

